AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 21 filers reported holding AKARI THERAPEUTICS PLC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,387,000 | -17.3% | 197,072 | 0.0% | 0.60% | -23.1% |
| Q3 2016 | $1,677,000 | -36.9% | 197,072 | 0.0% | 0.78% | -57.0% |
| Q2 2016 | $2,659,000 | -28.0% | 197,072 | -25.3% | 1.82% | -36.2% |
| Q1 2016 | $3,695,000 | -3.4% | 263,921 | 0.0% | 2.86% | -15.8% |
| Q4 2015 | $3,827,000 | – | 263,921 | – | 3.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7,941,867 | $1,443,037 | 1.26% |
| Omnia Family Wealth, LLC | 782,372 | $142,157 | 0.11% |
| NEA Management Company, LLC | 452,167 | $82,159 | 0.01% |
| Hikari Power Ltd | 130,821 | $24 | 0.00% |
| Bryn Mawr Capital Management, LLC | 100,000 | $18,170 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,264 | $5,495 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 261,192 | $47 | 0.00% |
| Renaissance Technologies | 283,550 | $52 | 0.00% |
| LPL Financial LLC | 134,453 | $24,430 | 0.00% |
| JPMORGAN CHASE & CO | 237 | $0 | 0.00% |